202 related articles for article (PubMed ID: 23526768)
1. Synthesis and biological evaluation of some 1,2-disubstituted benzimidazole derivatives as new potential anticancer agents.
Yurttaş L; Demirayak Ş; Çiftçi GA; Yıldırım ŞU; Kaplancıklı ZA
Arch Pharm (Weinheim); 2013 May; 346(5):403-14. PubMed ID: 23526768
[TBL] [Abstract][Full Text] [Related]
2. Microwave supported synthesis of some novel 1,3-diarylpyrazino[1,2-a]benzimidazole derivatives and investigation of their anticancer activities.
Demirayak S; Kayagil I; Yurttas L
Eur J Med Chem; 2011 Jan; 46(1):411-6. PubMed ID: 21122952
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization and evaluation of benzimidazole derivative and its precursors as inhibitors of MDA-MB-231 human breast cancer cell proliferation.
Thimmegowda NR; Nanjunda Swamy S; Kumar CS; Kumar YC; Chandrappa S; Yip GW; Rangappa KS
Bioorg Med Chem Lett; 2008 Jan; 18(1):432-5. PubMed ID: 17981032
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic, Antiproliferative and Apoptotic Effects of New Benzimidazole Derivatives on A549 Lung Carcinoma and C6 Glioma Cell Lines.
Yurttas L; Demirayak S; Ciftci GA
Anticancer Agents Med Chem; 2015; 15(9):1174-84. PubMed ID: 26138412
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and docking studies of novel antitumor benzimidazoles.
Omar MA; Shaker YM; Galal SA; Ali MM; Kerwin SM; Li J; Tokuda H; Ramadan RA; El Diwani HI
Bioorg Med Chem; 2012 Dec; 20(24):6989-7001. PubMed ID: 23123017
[TBL] [Abstract][Full Text] [Related]
6. Solvent free synthesis, anti-inflammatory and anticancer activity evaluation of tricyclic and tetracyclic benzimidazole derivatives.
Sondhi SM; Rani R; Singh J; Roy P; Agrawal SK; Saxena AK
Bioorg Med Chem Lett; 2010 Apr; 20(7):2306-10. PubMed ID: 20188544
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and anticancer activity of some 1,2,3-trisubstituted pyrazinobenzimidazole derivatives.
Demirayak Ş; Yurttaş L
J Enzyme Inhib Med Chem; 2014 Dec; 29(6):811-22. PubMed ID: 24456294
[TBL] [Abstract][Full Text] [Related]
8. Biological activity of bis-benzimidazole derivatives on DNA topoisomerase I and HeLa, MCF7 and A431 cells.
Alpan AS; Zencir S; Zupkó I; Coban G; Réthy B; Gunes HS; Topcu Z
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):844-9. PubMed ID: 18951286
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and anticancer activity of some novel 2-substituted benzimidazole derivatives.
Refaat HM
Eur J Med Chem; 2010 Jul; 45(7):2949-56. PubMed ID: 20399544
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and cytotoxicity evaluation of some benzimidazole-4,7-diones as bioreductive anticancer agents.
Gellis A; Kovacic H; Boufatah N; Vanelle P
Eur J Med Chem; 2008 Sep; 43(9):1858-64. PubMed ID: 18222567
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro cytotoxic evaluation of some thiazolylbenzimidazole derivatives.
Luo Y; Xiao F; Qian S; Lu W; Yang B
Eur J Med Chem; 2011 Jan; 46(1):417-22. PubMed ID: 21115212
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity.
Paul K; Bindal S; Luxami V
Bioorg Med Chem Lett; 2013 Jun; 23(12):3667-72. PubMed ID: 23642480
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel isatin-thiazoline and isatin-benzimidazole conjugates as anti-breast cancer agents.
Taher AT; Khalil NA; Ahmed EM
Arch Pharm Res; 2011 Oct; 34(10):1615-21. PubMed ID: 22076761
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel 1,2,5-trisubstituted benzimidazoles as potential antitumor agents.
Abonia R; Cortés E; Insuasty B; Quiroga J; Nogueras M; Cobo J
Eur J Med Chem; 2011 Sep; 46(9):4062-70. PubMed ID: 21719162
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and characterization of 2-substituted benzimidazoles and their evaluation as anticancer agent.
Azam M; Khan AA; Al-Resayes SI; Islam MS; Saxena AK; Dwivedi S; Musarrat J; Trzesowska-Kruszynska A; Kruszynski R
Spectrochim Acta A Mol Biomol Spectrosc; 2015 May; 142():286-91. PubMed ID: 25706598
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and preliminary evaluation of selected 2-aryl-5(6)-nitro- 1H-benzimidazole derivatives as potential anticancer agents.
Romero-Castro A; León-Rivera I; Avila-Rojas LC; Navarrete-Vázquez G; Nieto-Rodríguez A
Arch Pharm Res; 2011 Feb; 34(2):181-9. PubMed ID: 21380799
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization and biological evaluation of some 16β-azolyl-3β-amino-5α-androstane derivatives as potential anticancer agents.
Guo H; Zhang G; Zhang T; He X; Wu Z; Xiao Y; Pan Y; Qiu G; Liu P; Hu X
Eur J Med Chem; 2011 Sep; 46(9):3662-74. PubMed ID: 21641694
[TBL] [Abstract][Full Text] [Related]
18. 2-phenyl-1-[4-(2-piperidine-1-yl-ethoxy)benzyl]-1H-benzimidazoles as ligands for the estrogen receptor: synthesis and pharmacological evaluation.
Dettmann S; Szymanowitz K; Wellner A; Schiedel A; Müller CE; Gust R
Bioorg Med Chem; 2010 Jul; 18(14):4905-16. PubMed ID: 20598555
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of novel benzimidazole derivatives as sirtuin inhibitors with antitumor activities.
Yoon YK; Ali MA; Wei AC; Choon TS; Osman H; Parang K; Shirazi AN
Bioorg Med Chem; 2014 Jan; 22(2):703-10. PubMed ID: 24387981
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer.
Bistrović A; Krstulović L; Harej A; Grbčić P; Sedić M; Koštrun S; Pavelić SK; Bajić M; Raić-Malić S
Eur J Med Chem; 2018 Jan; 143():1616-1634. PubMed ID: 29133046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
